URNG.L vs. GNOM.L
URNG.L (Global X Uranium UCITS ETF USD Accumulating) and GNOM.L (Global X Genomics & Biotechnology UCITS ETF) are both exchange-traded funds - URNG.L is a Uranium fund tracking the Solactive Global Uranium & Nuclear Components, while GNOM.L is a Health & Biotech Equities fund tracking the Global X Genomics & Biotechnology UCITS ETF. Both are passively managed. Over the past 3 years, URNG.L returned 28.65%/yr vs 3.46%/yr for GNOM.L. At a 0.34 correlation, their price movements are largely independent. URNG.L charges 0.65%/yr vs 0.50%/yr for GNOM.L.
Performance
URNG.L vs. GNOM.L - Performance Comparison
Loading charts...
Different Trading Currencies
URNG.L is traded in GBP, while GNOM.L is traded in USD. To make them comparable, the GNOM.L values have been converted to GBP using the latest available exchange rates.
Returns By Period
In the year-to-date period, URNG.L achieves a -2.89% return, which is significantly lower than GNOM.L's 21.80% return.
URNG.L
- 1D
- 0.00%
- 1M
- -14.21%
- 6M
- -20.73%
- YTD
- -2.89%
- 1Y
- 11.83%
- 3Y*
- 28.65%
- 5Y*
- —
- 10Y*
- —
GNOM.L
- 1D
- 0.00%
- 1M
- 10.90%
- 6M
- 15.21%
- YTD
- 21.80%
- 1Y
- 61.34%
- 3Y*
- 3.46%
- 5Y*
- —
- 10Y*
- —
URNG.L vs. GNOM.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
URNG.L Global X Uranium UCITS ETF USD Accumulating | -2.89% | 58.50% | 2.96% | 30.86% | -39.68% |
GNOM.L Global X Genomics & Biotechnology UCITS ETF | 21.80% | 10.80% | -16.55% | -10.48% | -1.73% |
Correlation
The correlation between URNG.L and GNOM.L is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.39 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Apr 22, 2022 | 0.34 |
The correlation between URNG.L and GNOM.L shifts across timeframes, from 0.28 (3 years) to 0.39 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
URNG.L vs. GNOM.L — Risk / Return Rank
URNG.L
GNOM.L
URNG.L vs. GNOM.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X Uranium UCITS ETF USD Accumulating (URNG.L) and Global X Genomics & Biotechnology UCITS ETF (GNOM.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| URNG.L | GNOM.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.89 | ||
| Sortino ratioReturn per unit of downside risk | -2.25 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.34 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | 0.36 | 3.66 | -3.30 |
| Martin ratioReturn relative to average drawdown | 0.79 | 9.16 | -8.37 |
Loading charts...
Drawdowns
URNG.L vs. GNOM.L - Drawdown Comparison
The maximum URNG.L drawdown since its inception was -46.74%, smaller than the maximum GNOM.L drawdown of -67.55%. Use the drawdown chart below to compare losses from any high point for URNG.L and GNOM.L.
Loading charts...
Drawdown Indicators
| URNG.L | GNOM.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.74% | -67.55% | +20.81% |
Max Drawdown (1Y)Largest decline over 1 year | -32.59% | -16.99% | -15.60% |
Max Drawdown (3Y)Largest decline over 3 years | -38.98% | -45.06% | +6.08% |
Current DrawdownCurrent decline from peak | -29.33% | -36.84% | +7.51% |
Average DrawdownAverage peak-to-trough decline | -22.97% | -43.90% | +20.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.05% | 6.80% | +8.25% |
Volatility
URNG.L vs. GNOM.L - Volatility Comparison
Global X Uranium UCITS ETF USD Accumulating (URNG.L) has a higher volatility of 10.40% compared to Global X Genomics & Biotechnology UCITS ETF (GNOM.L) at 8.45%. This indicates that URNG.L's price experiences larger fluctuations and is considered to be riskier than GNOM.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| URNG.L | GNOM.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.40% | 8.45% | +1.95% |
Volatility (6M)Calculated over the trailing 6-month period | 34.88% | 21.47% | +13.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.15% | 29.21% | +20.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 41.49% | 32.06% | +9.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.49% | 32.06% | +9.43% |
URNG.L vs. GNOM.L - Expense Ratio Comparison
URNG.L has a 0.65% expense ratio, which is higher than GNOM.L's 0.50% expense ratio.
Dividends
URNG.L vs. GNOM.L - Dividend Comparison
Neither URNG.L nor GNOM.L has paid dividends to shareholders.
Frequently Asked Questions
URNG.L and GNOM.L have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, GNOM.L is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GNOM.L is cheaper with a 0.50% expense ratio, compared with 0.65% for URNG.L.
URNG.L is categorized as Uranium, while GNOM.L is Health & Biotech Equities. URNG.L tracks Solactive Global Uranium & Nuclear Components, while GNOM.L tracks Global X Genomics & Biotechnology UCITS ETF. Their fees differ too: 0.65% for URNG.L and 0.50% for GNOM.L.
Find the right allocation for URNG.L and GNOM.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer